Država: Francija
Jezik: angleščina
Source: HMA (Heads of Medicines Agencies)
febantel 525 mg, praziquantel 175 mg, pyrantel 175 mg
CEVA Animal Health
QP52AA51
Tablet
praziquantel, combinations
Dogs
2011-11-23
AN: 00824/2012 Revised: February 2013 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT X-SPECTRA Flavoured tablets for medium and small dogs [UK] CESTEM F tablets for dogs [FR] 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One tablet contains: ACTIVE SUBSTANCES: Febantel ................................................................................. 150 mg Pyrantel (as embonate) .......................................................... 50 mg Praziquantel ............................................................................. 50 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet. Yellow brown, oval tablet with a score line on both sides. The tablets can be divided into equal halves. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of mixed infections by cestodes and nematodes of the following species: Nematodes: Ascarids: _Toxocara canis_, _Toxascaris leonina _(adult and late immature forms)_ _. Hookworms: _Uncinaria stenocephala_, _Ancylostoma caninum _(adults). Whipworms: _Trichuris vulpis _(adults). Cestodes: Tapeworms: _Echinococcus _species, _(E. Granulosus, E. Multilocularis), Taenia _ species (T. hydatigena, T. pisiformis, T. taeniformis), _Dipylidium caninum _(adult and immature forms). AN: 00824/2012 Revised: February 2013 Page 2 of 6 4.3 CONTRAINDICATIONS Do not use in animals with a known sensitivity to the active ingredients or to any of the excipients. See section 4.7 below. 4.4 SPECIAL WARNINGS FOR EACH TARGET Preberite celoten dokument